Dr. Ignacio Amat Santos | Innovative Leadership | Best Researcher Award

Posted on by ScienceFather

Dr. Ignacio Amat Santos | Innovative Leadership | Best Researcher Award

University Clinic Hospital of Valladolid, Spain

Profile 

Orcid 

📚Early Academic Pursuits 

Dr. Ignacio J. Amat-Santos embarked on his medical journey with a strong foundation in cardiology and statistical research. He completed his cardiology training at the University Clinical Hospital of Valladolid in Spain, a prestigious institution known for its rigorous medical programs. During his training, he further enriched his expertise with an external stay at Klinikum Großhadern in Munich, Germany, where he gained invaluable international experience in advanced cardiac care.

Recognizing the importance of a multidisciplinary approach in medical research, Dr. Amat-Santos pursued a degree in statistics applied to biosanitary research from the Autonoma University in Barcelona, Spain. This unique combination of clinical and statistical expertise laid the groundwork for his future contributions to cardiology and medical research.

🏥Professional Endeavors 

Dr. Amat-Santos’ professional journey is marked by extensive training and practical experience in interventional cardiology. He honed his skills at the Quebec Heart & Lung Institute in Canada, one of the leading centers for cardiac care. His quest for excellence in clinical research led him to the Instituto de Salud Carlos III in Madrid, Spain, where he secured the competitive “Rio Hortega” contract. This opportunity allowed him to delve deeply into clinical research, culminating in his PhD, which was awarded the first national prize, a testament to his exceptional academic and research capabilities.

Currently, Dr. Amat-Santos serves as the Director of the Interventional Cardiology Department at the University Clinical Hospital of Valladolid, one of Spain’s largest and most renowned hospitals. In this role, he oversees a team of skilled professionals, ensuring the highest standards of cardiac care for patients.

🔬Contributions and Research Focus 

Dr. Amat-Santos has made significant contributions to the field of cardiology, particularly in the area of structural cardiac interventions. He is recognized as a key opinion leader in this domain, serving as a proctor for Transcatheter Aortic Valve Implantation (TAVI) as well as for tricuspid and mitral therapies. His expertise extends to complex coronary cases, where he acts as a proctor for chronic total occlusions.

Throughout his career, Dr. Amat-Santos has been the principal investigator in over 100 studies and has authored more than 300 scientific articles. His research has been published in prestigious journals such as The Lancet, New England Journal of Medicine, JACC Cardiovascular Interventions, and EuroIntervention. Some of his notable publications include:

  1. Baumbach A, van Royen N, Amat-Santos IJ, et al. “LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.” The Lancet. 2024.
  2. Biscaglia S, Guiducci V, Escaned J, et al; FIRE Trial Investigators. “Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.” N Engl J Med. 2023.
  3. Amat-Santos IJ, Estevez-Loureiro R, Sánchez-Recalde Á, et al. “Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation.” EuroIntervention. 2023.

🏅Accolades and Recognition 

Dr. Amat-Santos’ excellence in cardiology and research has been recognized through numerous accolades and awards. His PhD was awarded the first national prize, highlighting his outstanding research contributions. He is frequently invited to speak at international conferences and serves as an editor and author of several influential books in the field of cardiology.

His role as a professor of medicine at the University of Valladolid allows him to shape the next generation of cardiologists and researchers. He supervises several PhD projects, guiding students through their academic and research endeavors.

🌍Impact and Influence 

Dr. Amat-Santos’ impact on the field of cardiology extends beyond his clinical and research contributions. As a proctor for TAVI and other structural cardiac interventions, he plays a crucial role in training and mentoring other cardiologists worldwide. His expertise in complex coronary cases has led to advancements in the treatment of chronic total occlusions, improving patient outcomes.

His extensive publication record and involvement in over 100 studies demonstrate his commitment to advancing medical knowledge and improving patient care. His work on prosthetic valve endocarditis, commissural alignment in TAVR, and other critical areas of cardiology has influenced clinical practices and guidelines.

🌟Legacy and Future Contributions 

Dr. Amat-Santos’ legacy is characterized by his dedication to advancing the field of cardiology through research, education, and clinical practice. His contributions have significantly impacted the treatment of structural heart diseases and complex coronary conditions. As he continues to lead the Interventional Cardiology Department at the University Clinical Hospital of Valladolid, his influence on the field is poised to grow.

Looking ahead, Dr. Amat-Santos is likely to continue making groundbreaking contributions to cardiology. His ongoing research, mentorship of young cardiologists, and leadership in clinical practice ensure that his impact will be felt for years to come. His commitment to excellence and innovation in cardiology sets a high standard for future generations, cementing his legacy as a pioneer in the field.

Publications 

  1. ESTUDIO DE FLUJO AÓRTICO TRAS IMPLANTE DE PRÓTESIS DE VÁLVULA AÓRTICA TRANSCATÉTER EN FUNCIÓN DE LA ORIENTACIÓN DE LA PRÓTESIS. DISEÑO Y VALIDACIÓN DE SIMULACIÓN COMPUTACIONAL
  • Duration: 2024-01 to 2025-12
  • Granting Agency: Instituto de Salud Carlos III (Valladolid, ES)
  • Grant Number: DTS23/00127
  • Authors: TBD
  • Journal: TBD
  • Year: 2024

2. Implante de prótesis aórtica transcatéter para el tratamiento de prótesis mecánica aórtica disfuncionante: Estudio translacional de prueba de concepto. (TAMEC Study)

  • Duration: 2024-01 to 2024-12
  • Granting Agency: GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON (Valladolid, ES)
  • Grant Number: GRS 2917/A1/2023
  • Authors: TBD
  • Year: 2024

3. Estudio COMPLETE-2. Ensayo aleatorizado de estrategias de revascularización completa de lesiones no culpables guiadas por fisiología frente a estrategias de revascularización completa de lesiones no culpables guiadas por angiografía en pacientes con infarto agudo de miocardio y enfermedad coronaria multivaso

  • Duration: 2024 to present
  • Granting Agency: Canadian Institutes of Health Research y Abbott Medical Canada Co. (., CA)
  • Grant Number: NCT05701358
  • Authors: TBD
  • Journal: TBD
  • Year: 2024

4. Estudio COPERNICAN. REDUCED STENT STRATEGY VERSUS CONVENTIONAL PERCUTANEOUS CORONARY REVASCULARIZATION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

  • Duration: 2024 to present
  • Granting Agency: Fundación para la Investigación del Hospital Universitari La Fe (Valencia, ES)
  • Grant Number: NCT06353594
  • Authors: TBD
  • Journal: TBD
  • Year: 2024

5. Estudio CROSS. Registro prospectivo de la disrupcion de guías y microcatéteres coronarios en la ICP de lesiones crónicas totales ocluidas: El ESTUDIO CROSS

  • Duration: 2024 to present
  • Granting Agency: ICICOR (., ES)
  • Grant Number: NCT06353594
  • Authors: TBD

Prof. Sujuan Hu | Innovative Leadership | Best Innovation Award

Posted on by ScienceFather

Prof. Sujuan Hu | Innovative Leadership | Best Innovation Award

Kunming University, China

Profile 

Google Scholar 

🎓Early Academic Pursuits 

Sujuan Hu was born on August 25, 1987, and is a Chinese national. She embarked on her academic journey at Huazhong University of Science and Technology, where she pursued and successfully obtained her Ph.D. under the mentorship of Professor Bo Chi. This formative period from December 2012 to September 2015 laid a strong foundation for her future endeavors in the fields of chemical engineering and material science. Her doctoral studies were marked by a deep dive into the principles and applications of advanced battery technologies and photoelectrochemical systems.

💼Professional Endeavors 

Sujuan Hu currently serves as a key faculty member at Kunming University, where she engages in teaching and research. Her professional journey is characterized by a commitment to exploring innovative solutions in energy storage and conversion. Her work primarily focuses on the development of high-performance batteries and photoelectrochemical cells, aiming to address critical challenges in sustainable energy. This focus is evident in her numerous publications in high-impact journals and her active involvement in leading research projects.

🔬Contributions and Research Focus 

Dr. Hu’s research contributions are substantial and multifaceted, particularly in the realm of silicon-air batteries and photo-assisted zinc-air batteries. Her work encompasses a range of topics including the synthesis of novel electrocatalysts, the development of advanced battery materials, and the investigation of photoelectrochemical properties. Some of her notable publications include:

  1. Silicon-Air Batteries: An in-depth review published in Coordination Chemistry Reviews discusses the principles, current state, and future perspectives of silicon-air batteries. This work has garnered significant attention in the field, underscoring its impact on future energy storage technologies.
  2. Photo-Assisted Zinc-Air Batteries: Her research on flexible rechargeable photo-assisted zinc-air batteries, published in Energy Storage Materials, highlights the innovative use of photo-active bifunctional oxygen electrocatalysts. This work exemplifies her expertise in integrating photoactive materials with energy storage systems.
  3. Semiconductor Applications: Dr. Hu has extensively explored the use of semiconductor materials in various battery systems. Her publications in prestigious journals such as Chemical Engineering Journal and Chinese Chemical Letters detail the development of semiconductor-based electrocatalysts for enhanced battery performance and environmental sensing.

🏆Accolades and Recognition 

Dr. Sujuan Hu’s exemplary work has earned her numerous accolades, reflecting her prominence in the scientific community. Notably, she received the Yunnan Province Natural Science Award in 2022, a testament to her significant contributions to natural sciences. In 2018, she was recognized as part of the “Thousand Talents Program” of Yunnan Province for Young Talents, highlighting her potential and achievements as a young scientist.

🌍Impact and Influence 

Dr. Hu’s research has had a profound impact on the field of energy storage and conversion. Her innovative approaches to battery technology and photoelectrochemical systems have paved the way for advancements in sustainable energy solutions. Her work on silicon-air and zinc-air batteries, in particular, has the potential to revolutionize the way energy is stored and utilized, offering more efficient and environmentally friendly alternatives to conventional battery systems.

🌟Legacy and Future Contributions 

Looking ahead, Dr. Sujuan Hu is poised to continue her influential work in energy storage and photoelectrochemical systems. Her ongoing research aims to further explore the integration of novel materials and technologies to enhance the efficiency and performance of energy storage devices. As a leading figure in her field, she is expected to contribute significantly to the development of next-generation energy solutions, ensuring a lasting legacy of innovation and sustainability.

Publications 

Two-dimensional TiO2 (001) nanosheets as an effective photo-assisted recyclable sensor for the electrochemical detection of bisphenol A

  • Authors: Sujuan Hu, Yingjian Yu, Yu Guan, Yanhuan Li, Baoling Wang, Mingshan Zhu
  • Journal: Chinese Chemical Letters
  • Year: 2020

Ultrathin two-dimensional semiconductors for photocatalysis in energy and environment applications

  • Authors: Sujuan Hu, Mingshan Zhu
  • Journal: ChemCatChem
  • Year: 2019

Novel heterojunction photocatalysts based on lanthanum titanate nanosheets and indium oxide nanoparticles with enhanced photocatalytic hydrogen production activity

  • Authors: Sujuan Hu, Bo Chi, Jian Pu, Li Jian
  • Journal: Journal of Materials Chemistry A
  • Year: 2014

2D/1D heterostructure of g-C3N4 nanosheets/CdS nanowires as effective photo-activated support for photoelectrocatalytic oxidation of methanol

  • Authors: Jiayue Hu, Chaokai Yu, Chunyang Zhai, Sujuan Hu, Yuan Wang, Nianqing Fu, Lixi Zeng, Mingshan Zhu
  • Journal: Catalysis Today
  • Year: 2018

Visible light driven (Fe, Cr)-codoped La2Ti2O7 photocatalyst for efficient photocatalytic hydrogen production

  • Authors: Sujuan Hu, Lichao Jia, Bo Chi, Jian Pu, Li Jian
  • Journal: Journal of Power Sources
  • Year: 2014

Dr. Qijie Li | Innovative Leadership | Best Researcher Award | 3037

Posted on by ScienceFather

Dr. Qijie Li | Innovative Leadership | Best Researcher Award

West China Hospital of Sichuan University, China

🔗 Profile

Scopus

Early Academic Pursuits 📚

Qijie Li’s academic journey began with a profound interest in medical science and research, culminating in a Ph.D. from Sichuan University. His early academic pursuits were marked by a deep commitment to understanding chronic diseases and the physiological effects of high-altitude environments. During his postdoctoral fellowship at Sichuan University, Dr. Li developed a keen focus on the complex interplay between high-altitude conditions and various chronic diseases. This period laid the foundation for his future research and professional endeavors.

Professional Endeavors 🏥

Currently serving as an Assistant Research Fellow at West China Hospital of Sichuan University, Dr. Li has made significant strides in the field of medical research. His role involves conducting advanced research in chronic diseases, traumatic stress, and wound healing, particularly in high-altitude settings. Dr. Li’s professional journey is highlighted by his involvement in key research projects that explore the impacts of environmental stressors on human health. He is also an active member of several professional societies, including the Special Committee for Women and Children of the Sichuan Information Society of Traditional Chinese Medicine and the Branch of Nutrition Epidemiology of the Chinese Nutrition Society.

Contributions and Research Focus 🔬

Dr. Li’s research focus is primarily on chronic diseases prevalent in high-altitude regions and their management. His notable work includes investigating the effects of the HIF-2α inhibitor PT2385 on high-altitude polycythemia, a condition characterized by an abnormal increase in red blood cells. His research has demonstrated that PT2385 treatment significantly improves congestion phenotypes, reduces erythrocytes and hemoglobin levels, mitigates blood vessel formation, and alleviates lipid peroxidation and inflammation. This study not only provides valuable insights into the physiological and immunological impacts of PT2385 but also lays the groundwork for clinical applications in preventing and treating high-altitude polycythemia.

Dr. Li’s work also extends to traumatic stress and wound healing. His research into the role of adipose tissue and cells in innate immune regulation has opened new avenues for understanding the body’s response to stress and injury, with potential implications for accelerated rehabilitation and precision nursing.

Accolades and Recognition 🏆

Dr. Li has been recognized for his exceptional contributions to medical research and innovation. In 2020, he received the third prize in the Science and Technology Award of the Tibet Autonomous Region, a testament to his impactful research and dedication. His extensive list of publications, including articles in reputable journals such as the European Journal of Pharmaceutical Sciences and MedComm, underscores his scholarly achievements. Dr. Li’s work has garnered significant attention within the academic community, reflected in his high citation index and influential research findings.

Impact and Influence 🌍

Dr. Li’s research has had a substantial impact on both the scientific community and clinical practice. His studies on high-altitude chronic diseases and innovative treatment approaches have provided new perspectives on managing these conditions. By elucidating the mechanisms through which PT2385 and other treatments affect high-altitude polycythemia and related disorders, Dr. Li’s work contributes to the development of more effective therapeutic strategies. His research also influences clinical practices related to trauma care and wound healing, enhancing patient outcomes and recovery processes.

Furthermore, Dr. Li’s involvement in professional memberships and collaborations with institutions like Tibet Autonomous Region People’s Hospital amplifies his impact, fostering advancements in medical research and practice.

Legacy and Future Contributions 🚀

As Dr. Li continues to advance his research, his legacy is being shaped by his commitment to improving healthcare outcomes for individuals living in challenging environments. His pioneering work in high-altitude medicine and chronic disease management sets a high standard for future research in these areas. Looking ahead, Dr. Li’s future contributions are expected to focus on expanding the understanding of chronic disease mechanisms and developing novel treatment approaches.

His ongoing projects and collaborations suggest a promising trajectory for his research, with potential to influence global health practices and contribute to the scientific community’s knowledge base. Dr. Li’s dedication to advancing medical science and improving patient care reflects a lasting legacy that will continue to inspire and benefit future generations of researchers and clinicians.

In summary, Qijie Li’s academic and professional journey is characterized by his groundbreaking research, significant contributions to medical science, and recognition as a leading figure in his field. His work not only addresses pressing health issues but also paves the way for future advancements in medical research and clinical practice.

📚 Publications

Prof Dr. Mehlika Dilek Altıntop | Visionary Leadership | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Mehlika Dilek Altıntop | Visionary Leadership | Best Researcher Award

Anadolu University, Turkey

🔗 Profile

Google scholar 

Early Academic Pursuits 📚

Professor Doctor Ahmet Özdemir embarked on his academic journey at Anadolu University, Faculty of Pharmacy, where he completed his undergraduate degree in 1994. His commitment to the field of pharmaceutical chemistry was evident early on, as he swiftly progressed to obtain his Master’s degree in 1996 and his Doctorate in 2004, both from Anadolu University’s Graduate School of Health Sciences. During his Master’s studies, he focused on the synthesis, structure elucidations, and determination of physicochemical parameters of certain 2-substituted-1H-phenantro[9,10-d]imidazole compounds under the supervision of Prof. Dr. İlhan Işıkdağ. His PhD research, supervised by Prof. Dr. Gülhan Turan, delved into the synthesis of specific pyrazoline derivatives and their antifungal and antibacterial activities.

Professional Endeavors and Contributions 🏛️

Following his doctorate, Professor Özdemir began his professional career as a Research Assistant at Anadolu University’s Faculty of Pharmacy from 1997 to 2004. He quickly advanced through the academic ranks, becoming a Research Assistant Doctor in 2004, a Lecturer in 2005, an Assistant Professor Doctor in 2007, and finally achieving the title of Professor Doctor in 2015. His administrative roles have been equally noteworthy, including serving as the Associate Director of Anadolu University Yunus Emre Vocational School (2011-2014) and the Vice Academic Director of Anadolu University Open Education Faculty, Department of Health Administration since 2015.

Research Focus and Contributions to Medicinal Chemistry 🔬

Professor Özdemir’s research primarily focuses on medicinal chemistry, particularly the synthesis of bioactive compounds with potential therapeutic applications. His notable works include the synthesis and antimicrobial activity of various pyridinyliminothiazoline, triazolylbenzofuranamine, and pyrazoline derivatives. His research has resulted in numerous publications in international peer-reviewed journals indexed by SCI and SCI-Expanded. Some of his key publications include studies on the synthesis and antimicrobial activities of thiazole derivatives, which have shown significant potential in developing new antibacterial and antifungal agents.

Accolades and Recognition 🏆

Professor Özdemir’s dedication to research and academic excellence has been recognized through various awards. These include the Anadolu University Article Performance Award (2014, 2016, 2017, 2018, 2020), the Gold and Platinum Article Performance Awards in 2015, and the Anadolu University Academic Success Award in 2019. Additionally, his innovative work in the field of medicinal chemistry was honored with the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer,” presented at the 6th Istanbul International Inventions Fair.

Impact and Influence 🌍

Professor Özdemir has significantly impacted the field of medicinal chemistry through his extensive research and numerous publications. His work has contributed to the understanding and development of new synthetic routes for bioactive compounds, which hold promise for therapeutic applications. Furthermore, his role as a supervisor for master’s and doctorate dissertations has allowed him to mentor and guide the next generation of researchers, further amplifying his influence in the scientific community.

Legacy and Future Contributions 🔮

Professor Özdemir’s legacy in medicinal chemistry is marked by his innovative research, dedication to teaching, and numerous accolades. As he continues his academic and research pursuits, he is expected to further contribute to the development of novel therapeutic agents and inspire future researchers in the field. His ongoing projects and future research endeavors are anticipated to build on his previous work, exploring new frontiers in medicinal chemistry and potentially leading to breakthroughs in the treatment of various diseases.

In summary, Professor Doctor Ahmet Özdemir’s career is characterized by his unwavering commitment to research excellence, significant contributions to medicinal chemistry, and a lasting impact on the academic and scientific community. His journey from an aspiring pharmacy student to a distinguished professor and researcher serves as an inspiring testament to the power of dedication, innovation, and academic rigor.

📚 Publications

Prof Dr. Mehlika Dilek Altıntop | Visionary Leadership | Women Researcher Award

Posted on by ScienceFather

Prof Dr. Mehlika Dilek Altıntop | Visionary Leadership | Women Researcher Award

Anadolu University, Turkey

🔗 Profile

Google scholar 

Early Academic Pursuits 📚

Professor Dr. Mehlika Dilek Altintop began her academic journey at İkieylül Elementary School and Eskişehir Anatolian High School, where she laid the foundation for her future in science. She pursued her undergraduate studies at Anadolu University, Faculty of Pharmacy, from 2003 to 2007. Her passion for medicinal chemistry led her to continue her education at Anadolu University’s Graduate School of Health Sciences, where she completed both her Master’s degree (2007-2009) and Doctoral degree (2009-2012) in Pharmaceutical Chemistry.

Professional Endeavors 🏛️

Dr. Altintop’s professional career began as a Research Assistant at Anadolu University, where she contributed significantly to the Faculty of Pharmacy from 2010 to 2012. She advanced through the academic ranks, serving as a Research Assistant Doctor (2012-2014), Assistant Professor Doctor (2014-2015), Associate Professor Doctor (2015-2020), and has been a Professor Doctor since 2020. Her administrative roles include serving as the Erasmus/Farabi/Mevlana Assistant Coordinator, Associate Director of the Graduate School of Health Sciences, and Quality Coordinator, showcasing her leadership and commitment to academic excellence.

Contributions and Research Focus 🔬

Dr. Altintop’s research is centered on Medicinal Chemistry, with a focus on synthesizing novel pharmaceutical compounds and evaluating their biological activities. Her research includes the development of targeted anticancer agents and metabolic enzyme inhibitors. Notable works include her contributions to the synthesis and biological evaluation of various derivatives, such as triazolothiadiazine and thiazole derivatives. Her work has been published in prestigious journals, reflecting her role in advancing medicinal chemistry.

Accolades and Recognition 🏆

Dr. Altintop’s work has been widely recognized. She has received numerous awards, including the Anadolu University Faculty of Pharmacy Championship Award (2007), multiple Anadolu University Article Performance Awards, and the Turkish Pharmacists’ Association Academy of Pharmacy Encouragement Award (2019). Her innovative research has earned her the ISIF’21 Silver Medal for an invention related to lung cancer treatment. Her articles have been recognized as Top Cited Articles in various journals, highlighting her significant contributions to the field.

Impact and Influence 🌍

Dr. Altintop’s impact extends beyond her research. Her role as an Associate Editor and Editorial Board Member for various prestigious journals demonstrates her influence in the academic community. Her editorial work includes contributions to journals like Frontiers in Chemistry and Molecules, as well as special issues focused on anticancer drug discovery and small molecule therapies. Her guidance in supervising Master’s and Doctoral dissertations has shaped the careers of many emerging scientists.

Legacy and Future Contributions 🌟

Looking ahead, Dr. Altintop continues to be a driving force in Medicinal Chemistry. Her research endeavors aim to address pressing health challenges, such as cancer and metabolic disorders, through innovative pharmaceutical solutions. Her commitment to excellence and her role in shaping the future of medicinal chemistry ensure that her legacy will continue to inspire and influence future generations of researchers.

📚 Publications

Prof. Sheng Wang | Strategic Leadership | Best Researcher Award

Posted on by ScienceFather

Prof. Sheng Wang | Strategic Leadership | Best Researcher Award

National institute of metrology, China

🔗 Professional Profiles

📚 Summary:

Sheng Wang is an associate researcher at the National Institute of Metrology, China, specializing in pesticide purity and accurate measurement technology. His work enhances food safety and promotes international measurement equivalence. 🌟🔬

🎓 Education:

  • 🎓 Ph.D. in Analytical Chemistry
    • Jilin University, 2018

💼 Professional Experience:

🏛️ Associate Researcher
  • National Institute of Metrology, China
    📅 Visiting Scholar
  • International Bureau of Weights and Measures, 2023
    🔬 Key Contributions
  • Developed 10 national reference materials
  • Led/participated in 5 international comparisons
  • Published 19 SCI research papers and applied for 10 patents

Research Interests

🔬 Novel Materials and Methods
    • Multi-residue determination of pesticides in complex food matrices
    • Chromatography and mass spectrometry
    • Development and promotion of reference materials

📖Publication Top Noted

Neonicotinoid insecticides in plant-derived Foodstuffs: A review of separation and determination methods based on liquid chromatography

    • Authors: Yang, B.; Tu, M.; Wang, S.; Ma, W.; Zhu, Y.; Ma, Z.; Li, X.
    • Journal: Food Chemistry
    • Volume: 2024
    • DOI: 10.1016/j.foodchem.2024.138695
    • EID: 2-s2.0-85184665934

Simultaneous Determination of Neonicotinoid and Carbamate Pesticides in Freeze-Dried Cabbage by Modified QuEChERS and Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry

    • Authors: Yang, B.; Wang, S.; Ma, W.; Li, G.; Tu, M.; Ma, Z.; Zhang, Q.; Li, H.; Li, X.
    • Journal: Foods
    • Volume: 2023
    • DOI: 10.3390/foods12040699
    • EID: 2-s2.0-85148875017

Determination of eight neonicotinoid insecticides in Chinese cabbage using a modified QuEChERS method combined with ultra performance liquid chromatography-tandem mass spectrometry

    • Authors: Yang, B.; Ma, W.; Wang, S.; Shi, L.; Li, X.; Ma, Z.; Zhang, Q.; Li, H.
    • Journal: Food Chemistry
    • Volume: 2022
    • DOI: 10.1016/j.foodchem.2022.132935
    • EID: 2-s2.0-85128186243

Emulsification/demulsification method coupled to GC–MS/MS for analysis of multiclass pesticide residues in edible oils

    • Authors: Wang, S.; Li, X.; Li, M.; Li, X.; Zhang, Q.; Li, H.
    • Journal: Food Chemistry
    • Volume: 2022
    • DOI: 10.1016/j.foodchem.2022.132098
    • EID: 2-s2.0-85123031574

Mass balance method for SI-traceable purity assignment of synthetic oxytocin

    • Authors: Wang, S.; Wu, P.; Li, M.; Huang, T.; Shi, N.; Feng, L.; Li, H.
    • Journal: Journal of Pharmaceutical and Biomedical Analysis
    • Volume: 2022
    • DOI: 10.1016/j.jpba.2021.114401
    • EID: 2-s2.0-85117090699